1. Population Pharmacokinetic Modeling and Simulation of TV‐46000: A Long‐Acting Injectable Formulation of Risperidone. Issue 7 (4th March 2022) Authors: Perlstein, Itay; Merenlender Wagner, Avia; Gomeni, Roberto; Lamson, Michael; Harary, Eran; Spiegelstein, Ofer; Kalmanczhelyi, Attila; Tiver, Ryan; Loupe, Pippa; Levi, Micha; Elgart, Anna Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 7(2022) Page Start: 865 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO‐02, an extended release formulation of oxycodone with sequestered naltrexone. Issue 5 (22nd January 2015) Authors: Gandelman, Kuan; Lamson, Michael; Salageanu, Joanne; Bramson, Candace; Matschke, Kyle; Malhotra, Bimal Journal: Clinical pharmacology in drug development Issue: Volume 4:Issue 5(2015:Sep./Oct.) Page Start: 370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Single‐ and multiple‐dose study to evaluate pharmacokinetics, safety and tolerability in healthy volunteers: A comparison of extended‐release oxycodone with sequestered naltrexone 40 mg twice daily to oxycontin 40 mg twice daily and extended‐release oxycodone with sequestered naltrexone 80 mg once daily. Issue 5 (22nd January 2015) Authors: Gandelman, Kuan; Lamson, Michael; Bramson, Candace; Matschke, Kyle; Salageanu, Joanne; Malhotra, Bimal Journal: Clinical pharmacology in drug development Issue: Volume 4:Issue 5(2015:Sep./Oct.) Page Start: 361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗